Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
World Vitiligo Map
Your guide to the vitiligo community worldwide. Use the selector to filter by patient support groups, specialists, research centers, clinical trial locations, or World Vitiligo Day events.
Directory Information & Disclaimer
This free public directory gathers information from public sources to help connect our global community. Medical professionals and organizations listed are independent and not affiliated with or endorsed by the Vitiligo Research Foundation (VRF), and no fees are accepted for listings.
Because clinics, support groups, and specialists move or update their services over time, some information may occasionally become outdated. As a result, VRF cannot guarantee the complete accuracy or usefulness of listed third-party resources.
Help Us Keep the Map Accurate
Do you need to add a listing, update outdated details, or request a removal? Please reach out to us using the feedback form on our Contact Us page.
Search Map
6 records found for “NCT07223229” · show all
- Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Phase: PHASE2
Intervention: Biological: EI-001; Other: Placebo
Status: Open now
Organizer: Elixiron Immunotherapeutics (Hong Kong) Ltd.
Trial page: https://vrfoundation.org/trials/ei-001-antibody-treatment-for-nonsegmental-vitiligoMarvel Clinical Research, Huntington Beach, California, 17742, United States
- Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Phase: PHASE2
Intervention: Biological: EI-001; Other: Placebo
Status: Open now
Organizer: Elixiron Immunotherapeutics (Hong Kong) Ltd.
Trial page: https://vrfoundation.org/trials/ei-001-antibody-treatment-for-nonsegmental-vitiligoCenter for Clinical Studies, Houston, Texas, 77004, United States
- Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Phase: PHASE2
Intervention: Biological: EI-001; Other: Placebo
Status: Open now
Organizer: Elixiron Immunotherapeutics (Hong Kong) Ltd.
Trial page: https://vrfoundation.org/trials/ei-001-antibody-treatment-for-nonsegmental-vitiligoLinkou Chang Gung Memorial Hospital, Taoyuan, Taiwan
- Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Phase: PHASE2
Intervention: Biological: EI-001; Other: Placebo
Status: Open now
Organizer: Elixiron Immunotherapeutics (Hong Kong) Ltd.
Trial page: https://vrfoundation.org/trials/ei-001-antibody-treatment-for-nonsegmental-vitiligoApex Clinical Research Center, LLC (Mayfield), Mayfield Heights, Ohio, 44124, United States
- Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Phase: PHASE2
Intervention: Biological: EI-001; Other: Placebo
Status: Open now
Organizer: Elixiron Immunotherapeutics (Hong Kong) Ltd.
Trial page: https://vrfoundation.org/trials/ei-001-antibody-treatment-for-nonsegmental-vitiligoU Mass Chan Medical School, Worcester, Massachusetts, 01605, United States
- Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Phase: PHASE2
Intervention: Biological: EI-001; Other: Placebo
Status: Open now
Organizer: Elixiron Immunotherapeutics (Hong Kong) Ltd.
Trial page: https://vrfoundation.org/trials/ei-001-antibody-treatment-for-nonsegmental-vitiligoSkin Care Research, LLC, Hollywood, Florida, 33021, United States
FAQOther Questions
- Safety of clinical trials. Can my child leave it for any reason?
Pediatric vitiligo trials · Safety and choice Who watches your child, what may need to pause and what happens if your family changes its mind. Two studies discussed here are eva...
- Shall I take vitamin D for my vitiligo?
Vitamin D plays a central role in the prevention of different inflammatory and chronic diseases. Consuming 1,000–4,000 IU (25–100 mcg) of vitamin D3 daily should be ideal for mo...
- I have vitiligo: will my children have vitiligo, too?
If you have vitiligo, it’s natural to worry about your children. While there is a genetic component, vitiligo is not a straightforward hereditary disease like eye color or heigh...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.